טוען...
Biomarker-guided antibiotic therapy—strengths and limitations
Biomarkers as C-reactive protein (CRP) and procalcitonin (PCT) emerged as tools to help clinicians to diagnose infection and to properly initiate and define the duration of antibiotic therapy. Several randomized controlled trials, including adult critically ill patients, showed that PCT-guided antib...
שמור ב:
| הוצא לאור ב: | Ann Transl Med |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AME Publishing Company
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451622/ https://ncbi.nlm.nih.gov/pubmed/28603723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.04.04 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|